Pemphigus associated with ipilimumab therapy

Affiliations

¹ Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.
² Histocompatibility and Tissue Typing Laboratory, Thomas Jefferson University, Philadelphia, PA, USA.
³ Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA, USA.
⁴ Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA, USA.
⁵ SUNY Downstate Health Sciences University College of Medicine, Brooklyn, NY, USA.

Elizabeth Schoenberg et al. Int J Dermatol. 2021 Aug.

. 2021 Aug;60(8):e331-e333.

doi: 10.1111/ijd.15405. Epub 2021 Jan 7.

¹ Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.
² Histocompatibility and Tissue Typing Laboratory, Thomas Jefferson University, Philadelphia, PA, USA.
³ Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA, USA.
⁴ Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA, USA.
⁵ SUNY Downstate Health Sciences University College of Medicine, Brooklyn, NY, USA.

No abstract available

References

1. Brochado MJ, Nascimento DF, Campos W, et al. Differential HLA class I and class II associations in pemphigus foliaceus and pemphigus vulgaris patients from a prevalent Southeastern Brazilian region. J Autoimmun 2016; 72: 19-24.
1. Vodo D, Sarig O, Sprecher E. The GENETICS OF PEMPHIGUS VULGARIS. Front Med (Lausanne) 2018; 5: 226.
1. Li S, Zhang Q, Wang P, et al. Association between HLA-DQB1 polymorphisms and pemphigus vulgaris: a meta-analysis. Immunol Invest 2018; 47: 101-112.
1. Yan L, Wang JM, Zeng K. Association between HLA-DRB1 polymorphisms and pemphigus vulgaris: a meta-analysis. Br J Dermatol 2012; 167: 768-777.
1. de Sena Nogueira Maehara L, De-Souza-Santana FC, Porro AM, et al. HLA class II alleles of susceptibility and protection in Brazilian and Dutch pemphigus foliaceus. Br J Dermatol 2018; 178: e212-e214.